English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
Olive Oil by the Spoonful for Digestion: Healthy Habit or Hype?
Somewhere between the wellness TikToks and the Mediterranean-diet studies, a small ritual has quietly become a thing: people pouring a tablespoon of extra virgin olive oil, tipping it back, and swallowing it straight. No bread. No salad. Just the oil. And apparently it's helping them digest their lunch. I'll admit my first reaction was a small internal wince. Drinking oil? On purpose? But then I started hearing about it from more than one corner — friends who'd sworn off supplements, a nutritionist who'd been doing it for over a year, a couple of the participants I met at a plant-medicine integration circle who'd picked up the habit as part of cleaning up their gut before ceremony. So I dug in. Here's what the practice actually looks like, what the research does and doesn't say, and whether it's worth trying yourself. Olive oil has been the darling of nutrition research for decades. The long-running Mediterranean diet studies keep pointing at it as one of the reasons populations who eat this way tend to have better cardiovascular outcomes, lower systemic inflammation, and healthier cholesterol profiles. That much isn't in dispute. Most of us get our olive oil the sensible way — drizzled on a salad, splashed into a pan, poured over roasted vegetables. The straight-from-the-spoon crowd is doing something different. Their logic goes like this: if you eat mostly whole foods and rarely cook with much fat, you might not actually be getting enough of the good stuff. Taking a measured tablespoon before a meal is a way to guarantee the daily dose without changing the way anything tastes. It sounds a bit clinical, and honestly it is. But the people who do it consistently tend to describe it the way you'd describe brushing your teeth — an unglamorous small habit that becomes automatic after a few weeks. The most common thing people report — and the reason I kept hearing about the habit at all — is that meals feel easier. Less bloat. Less of that heavy, over-full sensation an hour after eating. The kind of vague digestive complaints most of us have made peace with because we assume they're just part of being an adult. There's some real science pointing toward why this might not be pure placebo. Extra virgin olive oil is loaded with polyphenols — plant compounds that appear to feed the beneficial bacteria in the gut, particularly strains of Lactobacillus and Bifidobacterium. Human trials looking at olive-oil-enriched diets have shown modest improvements in bloating and that frustrating sense of incomplete digestion. Fat also slows gastric emptying, which can help stabilise blood sugar and reduce the sugar-crash-then-crave cycle that leads to picking at whatever's in the fridge at 4 p.m. That said — and this is the honest caveat — gut biology is deeply personal. Some people will feel a difference within a week. Others will feel nothing. A few will feel worse, especially if their gallbladder isn't happy or if they've got existing bile-flow issues. If a tablespoon of oil on an empty stomach makes you queasy, listen to that. The routine is almost boringly simple. Pour a tablespoon of cold-pressed, extra virgin olive oil. Drink it. Wait ten or fifteen minutes. Eat lunch or dinner. That's the whole ritual. A few practical notes from people who've stuck with it: Here's my honest read after asking around and reading through the research: it's a legitimate habit, but it's also not magic. Olive oil is genuinely good for you, and getting a reliable daily dose isn't a bad idea if your usual meals don't include much fat. The digestion benefits some people report are plausible. The pre-ceremony crowd who use it as part of preparing their body for a retreat aren't wrong to include healthy fats in that prep — a well-nourished gut handles most things better, including the intense purgative experience of certain plant medicines. But the spoonful method isn't the only path to those benefits. If drinking oil sounds unpleasant to you, drizzle two tablespoons over your roasted vegetables at dinner and you've hit the same target. Whisk it into a dressing. Finish a bowl of lentil soup with a generous pour. The delivery vehicle doesn't really matter — what matters is that the oil is high quality, that you're consuming it consistently, and that you're not heating it into oblivion first (extra virgin olive oil handles moderate heat fine, despite what you may have read, but blasting it in a screaming-hot pan does degrade some of the beneficial compounds). Worth saying plainly, because the wellness internet has a habit of overpromising: a daily spoonful of olive oil is not going to undo a diet built around ultra-processed food. It won't compensate for chronic poor sleep. It won't repair a gut that's been battered by years of antibiotics without any rebuilding work. And it won't replace the deeper stuff that some people are actually reaching for when they start picking up small daily rituals — the sense of doing something intentional for themselves, of taking their body seriously. That last point is worth sitting with. Sometimes the value of a small habit isn't the habit itself. It's the fact that you showed up for it. If a morning tablespoon of olive oil is the thread that pulls you toward eating better, moving more, and paying attention to what your body is actually telling you, then it's doing meaningful work regardless of what the polyphenol content is up to. Try it if you're curious. Give it three or four weeks — habits need time to reveal whether they're actually doing anything. Pay attention to how your gut feels an hour after meals, how your afternoon energy holds up, whether the low-grade bloat that most people quietly live with starts to ease. If it helps, keep going. If it doesn't, no harm done, and you can go back to drizzling it on your salad like a civilised person. And if you're the kind of reader thinking about broader body-and-mind resets — plant-medicine retreats, integration work, longer-form healing journeys — small daily practices like this often become the scaffolding that makes the bigger experiences land. Curated psychedelic and plant-medicine retreats where preparation, nutrition, and integration are taken seriously can be browsed on our marketplace here.
Cooking, Dementia Risk, and Why Your Brain Wants You in the Kitchen
When did you last stand at a stove, chopping something, tasting as you went? If it was recently, your brain may quietly be thanking you. A new study out of Japan has been making the rounds in longevity circles, and the headline finding is genuinely surprising: cooking meals from scratch — even just once a week — appears to significantly reduce the risk of dementia in older adults. For inexperienced cooks, the drop was almost too large to believe at first glance. This isn't the sexiest wellness intervention. There's no retreat, no ceremony, no supplement stack. Just you, a cutting board, and something that used to be alive or growing. But if you're someone who thinks about long-term brain health — and increasingly, most of us are — this one deserves a slow read. Researchers pulled data from the Japan Gerontological Evaluation Study, a long-running project tracking the health of adults aged 65 and older. Nearly 11,000 participants were followed for six years, with their cooking habits recorded alongside standard measures of cognitive health. The team also asked participants to rate their own culinary skill, which turned out to matter more than you'd think. They controlled for the usual suspects — education, income, whether someone was retired, whether they lived alone. About half the participants cooked five or more times a week. Just over a quarter almost never cooked. Women cooked more than men. People who considered themselves skilled cooked more than people who didn't. None of that is shocking. What was shocking: by the end of the six-year window, roughly 1,200 participants had developed dementia — and the risk was meaningfully lower among those who cooked at home more often. One home-cooked meal a week was associated with a 23% reduction in dementia risk for men and 27% for women. For people who described themselves as inexperienced cooks, that same weekly meal was linked to a 67% reduction. Read that number again. The obvious answer is nutrition. If you're cooking, you're probably not eating ultra-processed food that day. And ultra-processed foods — the shelf-stable, hyper-palatable, engineered stuff — have been repeatedly linked to worse cognitive outcomes, cardiovascular problems, and metabolic disease. Cooking at home tends to mean more vegetables, more whole ingredients, less sugar, less industrial seed oil, less mystery. But nutrition can't be the whole story, because the study controlled for a lot of that. There's something about the act of cooking itself. Think about what happens when you make a meal from scratch. You're planning ahead — deciding what to make, checking what you have. You're doing sequencing — this needs to go in first, that gets added later, don't forget to preheat the oven. You're using your hands, your eyes, your nose. You're making small aesthetic judgments. You're timing multiple things at once. That's a cognitive workout dressed up as dinner. It engages memory, planning, spatial reasoning, sensory processing, and fine motor skills, all in one loose twenty-minute stretch. Neurologists have long argued that the best protection against cognitive decline is a life full of varied, moderately challenging mental activity. Cooking checks every box, and it does so several times a week without you noticing. The 67% figure for inexperienced cooks is the one that stopped me. Why would the benefit be so much larger for people who don't really know what they're doing? Probably because for a beginner, cooking is genuinely hard. You have to think about everything. Following an unfamiliar recipe is closer to learning a language than performing a routine. The novelty demand is enormous — which is exactly the kind of cognitive stimulation researchers believe drives the protective effect. For a lifelong cook, throwing together a stir-fry is muscle memory. For someone who's never made one, it's a small mental adventure. There's a lesson here that goes beyond cooking. Doing something slightly difficult, slightly outside your normal range, is where the brain benefits live. Comfort and repetition are pleasant. They don't build resilience. None of this replaces the other pillars of brain health. Sleep, movement, social connection, blood sugar control — these are still the heavy lifters. But cooking is interesting because it's low-cost, low-friction, and produces something you were going to need anyway (food). It's not another item on the wellness to-do list. It's just dinner, done differently. Some practical takeaways worth sitting with: Zoom out for a minute. What this study is really pointing at, I think, is a truth that keeps showing up in different corners of health research: the parts of modern life we've optimized away are often the parts that were keeping us well. Walking to places. Preparing our own food. Sitting with other people for meals. Being bored occasionally. Making things with our own effort. The convenience economy sold us time. What it took in return was engagement — the small, repeated acts of paying attention that keep a mind supple. Cooking is one of the last of these that's still socially normal to do. Nobody thinks you're strange for making soup. And apparently, making soup might help keep your memory intact into your eighties. This overlaps with a lot of what people describe finding on longer wellness retreats, plant-medicine journeys, or contemplative sits — the sense that slowing down and doing something with your hands changes how the brain feels. You don't need an ayahuasca ceremony to get some version of that (though the ceremonies have their own gifts). You need a knife, a pan, and about forty minutes. If you're the kind of person who reads about brain health because you're already thinking hard about how to age well — and if you're on this site, you probably are — then the invitation here is genuinely simple. Make one meal from scratch this week. Chop something. Salt something. Taste as you go. Notice how much of your brain lights up doing it. And if you're someone whose interest in cognitive longevity has led you toward deeper work — the kind involving stillness, integration, or plant medicine — a curated selection of relevant retreats can be browsed on our marketplace here. Sometimes the smallest daily acts and the biggest immersive ones point at the same thing: pay attention, do it yourself, and stay curious for as long as you can.
From FDA Approval to Your Therapist's Office: The Long Road Psychedelic Medicines Still Have to Walk
Here's a scene that keeps repeating itself in psychedelic circles. Somebody reads a headline — MDMA showing strong Phase 3 results, psilocybin racking up breakthrough designations, ibogaine being fast-tracked in Texas — and messages their friend group: this is it, it's finally happening. And it is happening, sort of. Just not the way most people assume. Because approval isn't access. A drug can clear the FDA and still be years away from the average person with treatment-resistant depression or PTSD walking into a clinic and receiving it. The path from a regulatory yes to a patient actually sitting on a couch, eyes closed, headphones on, working through their trauma with a trained therapist — that path is long, weird, and full of choke points nobody talks about in the excited threads on X. If you're one of the many readers quietly researching psychedelics as a possible way through addiction, depression, or a stuck life pattern, understanding this gap matters. It shapes what's realistically available to you right now, what might be available in two years, and why so many people are still traveling to legal jurisdictions abroad to sit with plant medicines like ayahuasca and psilocybin rather than waiting for the domestic system to catch up. Let's say a psychedelic-assisted therapy gets FDA approval tomorrow. Champagne corks pop in a few Bay Area boardrooms. Now what? The drug has to be scheduled by the DEA, which for a Schedule I substance means moving it — usually to Schedule II or III — through a formal rulemaking process. That alone typically takes months. Sometimes longer if there's political friction, and psychedelics generate plenty of that. Once scheduled, the substance needs a full Risk Evaluation and Mitigation Strategy — REMS, in the acronym-heavy language regulators love. For psychedelics, REMS programs are unusually intricate because the drug isn't a pill you take home. It's administered in-clinic, over hours, in the presence of trained providers. So the REMS has to specify who can prescribe it, who can administer it, what the room needs to look like, how patients are screened, how adverse events are reported, and how the whole apparatus is audited. Then comes the therapist and facilitator training bottleneck. Psychedelic-assisted therapy isn't like handing someone an SSRI prescription and telling them to check back in six weeks. It requires trained dyads — often two providers per session — who understand set and setting, integration, and how to sit calmly with someone who is, for a few hours, having the most intense internal experience of their life. Training programs exist, but scaling them to meet potential demand? That's a workforce problem we haven't solved. Even once the drug is scheduled and providers are trained, there's the small matter of who pays. A single MDMA-assisted therapy protocol can run three preparation sessions, three medicine sessions of eight hours each with two therapists, and multiple integration sessions afterward. Do the math on clinician time alone and you're looking at something that costs, conservatively, ten to fifteen thousand dollars per course of treatment. Some estimates run higher. Will insurers cover it? Some will, eventually, especially if the outcomes data holds up in the real world. Medicare and Medicaid will move slower than commercial plans. And in the meantime, coverage gaps mean the people most likely to benefit — those with severe, chronic, treatment-resistant conditions who often can't work full-time — are exactly the people least able to pay out of pocket. That's a bitter irony the field hasn't reckoned with honestly enough. State-level rollout adds another layer. Even a federally approved medicine has to be integrated into each state's healthcare system, licensure boards, and controlled-substance rules. Oregon and Colorado have built their own regulated psilocybin frameworks outside the FDA pathway entirely, which creates a patchwork nobody quite knows how to read. A therapy legal in one state might be inaccessible one border over. All of this is why the international retreat scene isn't disappearing anytime soon. When people ask me why anyone would fly to Peru, Costa Rica, the Netherlands, or Mexico to work with ayahuasca, psilocybin, or ibogaine, this is a big part of the answer. The domestic clinical infrastructure isn't ready. Even under the most optimistic timeline, meaningful access at scale in the U.S. is probably three to seven years away depending on the substance and the indication. Meanwhile, master plants like ayahuasca and huachuma have been used ceremonially for centuries — sometimes millennia — by traditions that have developed their own protocols for safety, preparation, and integration. Those protocols are not the same as clinical medicine. They're not better or worse in some absolute sense; they're different tools for overlapping problems. For someone with severe addiction who's exhausted the conventional options, an ibogaine clinic in Mexico or an ayahuasca center in Peru may be the most realistic path currently available. That said, the retreat world is uneven. Some centers are exceptional. Others are careless, and a small number are frankly dangerous. If you're considering this route while the domestic system catches up, the vetting work falls entirely on you. If you're actively researching a retreat rather than waiting for a future FDA-approved clinic near you, here's what I'd tell a friend to look at: Here's the uncomfortable truth about the regulatory slog. A lot of the delay between approval and access is genuinely protective. Rushed rollouts of powerful psychoactive medicines into a healthcare system that isn't prepared for them would produce harm — bad experiences, poorly trained providers, insurance denials that leave people mid-protocol, media backlash that sets the whole field back a decade. The people building the frameworks slowly, arguing over REMS provisions and training standards, are (mostly) trying to prevent that. The frustrating flip side is that people suffering right now don't have the luxury of a five-year wait. Someone with treatment-resistant depression, watching another antidepressant fail, doesn't want to hear about a Phase 3 readout that might, in theory, lead to a therapy their insurance might, in theory, cover in 2029. That tension between doing this responsibly and doing this urgently is the defining fight of the field right now, and I don't think there's a clean answer. What I'd offer, if you're weighing all of this personally: educate yourself deeply before you commit to anything. Read the actual trial data, not just the press releases. Talk to people who've been through it — both the ones who found something and the ones who didn't. Consider your own medical situation with real honesty. And if you decide a retreat is the right next step for you while the domestic system continues its slow build, take the vetting work seriously. For readers who want to look at what's actually available now, a curated selection of ayahuasca, psilocybin, and ibogaine retreats can be browsed on our marketplace here. The regulatory story will keep unfolding in headlines for years. Your own decision about whether, when, and where to sit with these medicines is a smaller, more personal thing — and it deserves the kind of careful attention that a policy timeline can't give you.
Depression, Metabolism, and the Pancreas: What a New Study Really Tells Us
Depression is loud in some ways and quiet in others. The loud part — the fatigue, the flat mornings, the sense that everything requires more effort than it should — most people who've been there can describe without much prompting. The quiet part is what depression is doing to the rest of the body while all of that is happening. Sleep gets ragged. Appetite swings. Movement drops off. Stress hormones stay elevated for longer than they were designed to. A new analysis out of the UK Biobank adds another odd finding to that quiet-part list. Researchers followed more than a quarter of a million adults for almost fourteen years and found that people with major depressive disorder had a 47% higher risk of developing chronic pancreatitis than people without it. That's a number worth sitting with — but also worth unpacking carefully, because the headline is more interesting than it is scary. The researchers pulled data on 273,524 adults who had no pancreas disease at baseline. They tracked them for a median of 13.7 years to see who eventually developed chronic pancreatitis — a condition where the pancreas becomes persistently inflamed, sometimes causing ongoing abdominal pain, digestive trouble, and, in more serious presentations, problems with how the body handles blood sugar. Alongside that, the team analysed blood samples for markers tied to metabolism: triglycerides, cholesterol fractions, various fatty acids. The question wasn't just whether depression and pancreatitis showed up together in the same people. It was whether metabolic differences might help explain why they showed up together. What they found: people with major depressive disorder had noticeably different lipid profiles — higher levels of certain triglycerides, lower levels of some unsaturated fatty acids — and those metabolic patterns seemed to account for part of the increased pancreatitis risk. Not all of it. But a meaningful slice. Short answer: probably less than that 47% figure suggests at first glance. Here's the thing about relative risk numbers — they always sound more dramatic than the underlying reality. Chronic pancreatitis is uncommon to begin with. In both the depressed and non-depressed groups in this study, the absolute number of new cases was small. A 47% bump on top of a small number is still a small number. So no, this isn't a reason for anyone with depression to start googling pancreas symptoms at 2 a.m. What it is, though, is another data point in a growing pile suggesting that mental health and physical health aren't really separate systems. They lean on each other constantly, and when one struggles, the other usually shows it somewhere. Depression does a lot of things to metabolic function, and most of them are downstream of behaviours the illness makes harder. People with depression, on average, move less. They sleep worse. They're more likely to smoke, drink more than they'd like to, and carry extra weight. Stress hormones stay elevated. Insulin sensitivity often drops. All of that shows up in bloodwork over time. Several of those factors — heavy alcohol use in particular, but also smoking and metabolic dysfunction — are already known to raise pancreatitis risk on their own. The researchers accounted for many of these variables statistically, and the association between depression and chronic pancreatitis still held. That's what makes the metabolic-mediator finding interesting: it hints that depression may be nudging pancreatitis risk partly through subtle shifts in how the body processes fat and sugar, not only through obvious lifestyle differences. Still, this was an observational study. It can't tell us whether depression itself is doing the damage, whether the metabolic changes are the real driver, or whether something else — chronic inflammation, gut-brain axis stuff, medication effects — is quietly involved in the background. You don't need a new thing to worry about. You need a way to think about your health as one integrated thing rather than a mental column and a physical column. A few practical takeaways worth actually acting on: Increasingly, people struggling with depression that hasn't shifted under conventional treatment are looking at psychedelic-assisted approaches — ayahuasca, psilocybin, ibogaine — as part of a broader recovery arc. Whatever your view on that, one thing keeps showing up in participant accounts and in the small but growing body of clinical research: when the depressive fog lifts, even partially, the physical-health follow-through tends to improve too. People sleep. They cook. They move. They stop treating their bodies like a rental car they don't own. That's not a claim that a plant-medicine retreat will lower anyone's pancreatitis risk. It's a broader observation. Whatever gets someone back into a functional relationship with their own body — therapy, medication, ceremony, community, exercise, or some combination — is likely doing quiet good in places nobody's measuring yet. Studies like this one are catching up slowly with what people who work in mental health have long suspected: the split between mind and body is administrative, not real. If you're weighing plant medicine as one option in a longer recovery journey — particularly for treatment-resistant depression — the honest advice is to research carefully, screen your medical history with someone who actually knows the substance in question, and think seriously about the integration work that follows the ceremony. For readers who want to explore what's out there, a range of vetted plant-medicine and psychedelic retreats can be browsed on our marketplace here. One study doesn't change medicine. But it does add to a pattern worth paying attention to: depression leaves fingerprints on organs and systems well outside the brain. That's not a reason to catastrophise. It's a reason to treat mental health as a health issue in the fullest sense — something with real, measurable effects on the body over years — and to give it the same seriousness you'd give a persistent physical symptom. The pancreas is a small, quiet organ most people never think about until it stops behaving. Turns out it may have been listening to how the rest of you was doing all along.
Living With PMDD: What 20 Years of Misdiagnosis Taught Me About Reclaiming Yourself
For roughly half of every month, I felt like a stranger inside my own head. The other half, I was steady. Clear. The kind of person who answered messages on time, kept promises to herself, and moved through the day without flinching. Then, almost overnight, something inside me would tip over. A different woman would show up in my body — sharper, more brittle, convinced that everything good in my life was quietly falling apart. It took me nearly twenty years to learn that this had a name: Premenstrual Dysphoric Disorder, or PMDD. And by the time I got there, I had lost count of the diagnoses, the medications, and the quiet moments where I wondered if maybe the darker version of me was the real one. My symptoms started at fourteen, the same year my family lost almost everything after a bad business call from my dad. House, work, community — gone. Grief was the wallpaper of our lives. So when I began crying without warning, or lying in bed watching the light shift across the ceiling for hours, the explanation felt obvious. Of course I was struggling. Look at what had happened. That explanation stuck around for a decade. It was convenient. It also wasn't quite right. Between fourteen and twenty-five, I sat in enough clinicians' offices to lose track. I was told it was depression. Then anxiety. Then, briefly, bipolar disorder. Each label came with a new prescription pad and a new theory. None of them held up for long, because none of them accounted for the thing that was actually happening — a rhythm. A pattern. A version of me that arrived and left on a schedule my doctors weren't asking about. After enough failed treatments, I stopped believing the labels and started believing something worse: that the problem was just me. Not chemistry, not biology, not a condition — me. Not disciplined enough. Not resilient enough. Not built for a normal life. Here's what I want people who haven't lived this to understand. It wasn't a bad mood. It wasn't being cranky before my period. It was a full-scale personality shift that arrived with terrifying certainty. During the good weeks, I could feel deeply secure in a relationship. Loved. Sure of the person next to me. Then, within a day or two, that same relationship would feel like a trap I needed to escape from, and I'd be halfway convinced I had to end things by dinner. It didn't present as fear. It presented as clarity. That's what made it so dangerous — I trusted the voice. I acted on it. I hurt people I loved based on it. At work, the same thing. One week I could speak up on a call without a second thought. The next, unmuting my microphone felt physically difficult. I told colleagues I was tired, or overloaded, or needed a break — anything that sounded less alarming than the truth, which was that I genuinely didn't know why my own mind kept turning against me. And my body was in on it too. Bloating that felt disproportionate. Migraines. A strange, floating exhaustion. A sense of being dropped into a body I didn't recognize. Food became its own quiet battlefield, with weeks where I felt like I was watching myself eat from across the room, unable to stop, followed by weeks of overcorrection. That cycle eventually contributed to an eating disorder I'm still unwinding. I got my first period at fourteen. By my early thirties, when I finally sat down and did the arithmetic, the number stopped me cold. Nearly two decades. If half of every month had been unlivable, that meant I had spent close to ten years — a full decade — trying to recover from my own biology. The grief of that isn't only about looking back. It reshapes how you think forward. I'd always wanted kids. I'd been a nanny, an au pair, a teacher. Loving children was not the question. Consistency was. If I couldn't count on my own steadiness two weeks out of every four, what did that mean for a small person who was counting on me? That was the question that finally pushed me to stop accepting the answers I'd been given. I started tracking everything. Not in a wellness-influencer way — in a survival way. Sleep. Food. Mood. What I said in an argument and when. Which days I couldn't get out of bed. Which days I felt like myself again. Once you see the pattern, you can't unsee it. Mine mapped almost exactly onto the second half of my cycle — the luteal phase. Around the same time, I started reading accounts from other women online describing symptoms that mirrored mine with unsettling precision. The acronym kept coming up: PMDD. I built a document. Symptoms. Timeline. Every medication I'd tried. Every past diagnosis. I brought it to two OB-GYNs and asked, plainly, if this could be what I had. Both dismissed the idea. Neither seemed particularly familiar with the condition. I was told, essentially, that hormones weren't the right place to look and that I should go back to a psychiatrist. I left those appointments with a specific kind of anger — the kind that comes from knowing something is wrong and realizing the person in the chair across from you has already decided not to look. But something had also shifted in me. I understood, finally, that no one was going to care about finding this answer as much as I did. The third OB-GYN listened. That's where I got the diagnosis. PMDD is not severe PMS. It's a hormone-based mood disorder rooted not in abnormal hormone levels but in an abnormal sensitivity to the normal hormonal shifts of the menstrual cycle. Those shifts appear to affect neurotransmitters like serotonin, which is why the symptoms can look so much like a mood disorder — because functionally, during those days, they are one. Estimates suggest PMDD affects somewhere between 3 and 8 percent of menstruating women. It's frequently mistaken for depression, anxiety, or bipolar disorder, which is why so many of us spend years bouncing between diagnoses that almost fit but never quite explain the cyclical nature of what's actually happening. It's also serious. In its severest forms, PMDD is associated with dramatically elevated rates of suicidal thoughts and attempts. This is not a lifestyle inconvenience. It is a legitimate medical condition that deserves the same rigor and research funding we give other mood disorders — and doesn't yet get. I wish I could tell you there's a single fix. There isn't. What has worked for me has been layered, and it took time to assemble. The single most useful mental tool I've built is this: no major life decisions during an episode. Not about relationships, jobs, moves, or money. If the thought arrives during the luteal phase, it waits. Sometimes it survives the wait and turns out to be real. Usually it doesn't. I'll add something the medical literature is only beginning to catch up with. A growing number of women I've spoken to living with PMDD, trauma, and disordered eating have found meaningful support through carefully guided psychedelic and plant-medicine experiences — psilocybin retreats, ayahuasca ceremonies, integration work afterward. It isn't a cure. It isn't for everyone. And it absolutely isn't a replacement for a proper diagnosis and ongoing medical care. But for those of us who have spent years feeling fractured by our own biology, sitting with a skilled facilitator in a well-run retreat container can offer something that pharmaceuticals often can't: a felt sense of wholeness, even briefly, and the beginning of a different relationship with the parts of yourself you've been at war with. If that direction pulls at you, do the research slowly. Vet the facilitators. Ask about their screening protocols, especially around mood disorders and SSRIs. And treat integration afterward as more important than the ceremony itself. If something in your life feels cyclical, intense, and deeply out of alignment with the person you know yourself to be during your clearer weeks — pay attention to that. Track it. Write it down for three months before you dismiss it. Bring your data to a doctor and, if that doctor waves you off, bring it to another one. Then another. You are not too much. You are not failing at being a person. You may simply be dealing with a condition that most of the medical world hasn't been trained to see, and the responsibility of connecting the dots has fallen, unfairly, to you. Give yourself the same rigor you would give a friend describing these symptoms. You'd believe her. You'd help her look. Do that for yourself. For readers exploring how plant-medicine work might complement the healing they're already doing around mood, trauma, or cyclical suffering, a range of curated psychedelic and plant-medicine retreats can be browsed on our marketplace here. Whatever path you choose, the first step is the same — trusting that what you've been feeling is real, and worth investigating properly.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
The Three Poisons of Buddhism: Practices to Loosen Their Grip
There's an old Buddhist diagnosis of why we suffer that I keep coming back to, especially in the days after a ceremony or a hard week or a conversation I wish I'd handled better. It says the mess we make of our inner lives comes down to three things: wanting, pushing away, and checking out. The tradition calls these the three poisons — greed, hatred, and delusion — and almost every spiritual bruise you can name traces back to one of them. What I find remarkable is how honest the framework is. It doesn't ask you to believe anything supernatural. You can test it against your own week and see if it holds up. It usually does. Most religions agree that suffering exists and that wisdom and kindness reduce it. Buddhism goes further and names the mechanism. According to the second noble truth, we suffer because we misread reality. We keep expecting things — including ourselves — to be solid and permanent. They aren't. Everything shifts. Everything ends. And yet we cling to a made-up center called “me,” and organize our whole life around defending it. Once you've built that fortress, the three poisons run the operation. You chase what feels good for the self (attachment). You shove away what threatens it (aversion). And everything that neither flatters nor threatens you gets ignored (indifference). The old texts picture these as a rooster, a snake, and a pig — the greedy one, the angry one, and the checked-out one, chasing each other in a circle at the hub of the wheel of existence. From those three, the tradition says, sprout the “eight worldly concerns” — pleasure and pain, praise and blame, fame and obscurity, gain and loss. That list is really just shorthand. In practice, the ego finds infinite ways to slice the world into for-me and against-me. That slicing is the whole problem. Here's the thing: you already know what it feels like to be free of them, even if only for a minute. Think of someone you love without conditions — a child, a partner, a friend, an old dog. In the moment you'd trade your comfort for theirs without a second thought, the poisons simply aren't there. No grasping. No aversion. No fog. Just a clear, warm attention that costs you nothing. That's the state the practices below are trying to make more available. Not as a peak experience, but as a baseline. Below are three angles on the same work — mindfulness, love, and letting go. You don't have to pick one. They stack. The Pali word for the poisons is kilesas. Translators have called them defilements, afflictions, stains — but the phrasing I like best is “torments of the heart.” That's what they are. They aren't character flaws stamped into you at the factory. They're weather systems that pass through, and if you're not paying attention, you'll mistake them for the sky itself. The trap is identification. The moment you tell yourself “I'm a greedy person” or “I'm an angry person,” you've handed the poison a permanent lease. Mindfulness cuts that lease short by treating each surge of craving or resentment as a thing to be observed rather than a thing to be. You get better at whatever you rehearse — so if you meet greed with more grasping (even grasping for it to go away), you strengthen greed. If you meet anger with more anger, you know how that story ends. A small example. A friend of mine adopted a dog who snores like a chainsaw. For months she'd wake up furious every night. The snoring didn't change. Her relationship to it did — she started noticing the annoyance, letting it exist without arguing with it, and watching it pass. Now she sleeps. The dog still snores. This is what practice looks like in real life. Small, unglamorous, effective. The second angle is the heart. Three classical practices — generosity (dana), loving-kindness (metta), and tonglen — map cleanly onto the three poisons. They're not sentimental. They're specific medicines for specific illnesses. Generosity treats greed. Craving is rooted in a felt sense of scarcity — that there isn't enough, that you aren't enough. Giving something away, whether it's money, time, attention, or a genuine listening ear, quietly contradicts that belief. Every act of dana is a small piece of evidence that you already have enough to share. Repeat it often enough and the panic-hoarding reflex starts to relax. Loving-kindness treats hatred. Aversion depends on the story that some people are fundamentally separate from you — that they're on the other team. Metta practice is the deliberate, repeated wish for the wellbeing of yourself, then those you love, then those you're neutral about, and finally those you can't stand. James Baldwin wrote that people cling to their hates because they sense that once the hate is gone, they'll have to face the pain underneath it. That's exactly what metta gently exposes. Tonglen treats delusion. The core delusion is the sense of being a separate self, cut off from everyone else's suffering. Tonglen practice inverts our normal reflex — instead of breathing in pleasant things and pushing away unpleasant ones, you breathe in the suffering of others and breathe out relief and space. It sounds counterintuitive. It works. Over time it dissolves the wall between “my pain” and “their pain” and reveals what was always true — that they were never separate. A note on trauma, because it matters here. A lot of us are walking around with unmetabolized personal and collective trauma — pandemic aftermath, generational grief, the weight of histories most of us didn't consent to inherit. One hallmark of trauma is the conviction that you're alone in your suffering and somehow to blame for it. That's hatred pointed inward, and it thickens the fog. Tonglen doesn't erase trauma, but it slowly reintroduces the truth that suffering is shared. That alone can loosen a lot. Underneath greed, hatred, and delusion is one common muscle — grasping. Attachment is grasping at what you want. Aversion is grasping at the version of reality where the unwanted thing isn't there. Ignorance is grasping at a familiar story about who you are and what the world is, and refusing to look at anything that contradicts it. Three flavors, one grip. So the question that sits at the start of the Buddhist path and at every step after is a plain one: of the things you're holding on to, which are you afraid to put down? Your honest answer says more about who you think you are than any personality test ever will. Is it the boxes in the basement? A story about your career? A grudge you've carried for a decade? A spiritual identity? Even the framework of Buddhism itself can become something you clutch. This isn't a moral judgment. The thing in your hand isn't necessarily bad. Renunciation, in this sense, isn't about giving up pleasure or possessions. It's about noticing where the grip has become the problem — where you're holding so tightly that the holding itself is what's hurting. People who sit with ayahuasca or psilocybin often describe experiences that look, from a distance, like a chemically assisted crash course in exactly this teaching. The self-concept loosens. The grip weakens. You watch your attachments, your resentments, and your convenient fictions from a small distance and understand — often for the first time — that you aren't any of them. That's a real experience. It can also be brief. The three poisons framework becomes useful in the days and weeks after such an experience, because it gives you language for what you saw and a set of practices for keeping the door open. A single ceremony can show you the room. Mindfulness, the heart practices, and the daily work of letting go are how you keep walking back in when the door starts to close. Integration, in other words, is not a mystery. It's just this — noticing the poisons in real time and choosing a different response, over and over, until the choosing becomes second nature. If any of this resonates and you're weighing a retreat as part of your own inquiry, a range of curated plant-medicine and psychedelic retreats can be browsed on our marketplace here. Whatever you do next, the work is the same — see the grasping, meet it kindly, and let a little more of it go each time.
Can Psilocybin Mushrooms Really Change Your Life? An Honest Look
Every few weeks someone posts a version of the same story online: shrooms saved my life. The details shift — depression that wouldn't lift, a decade of drinking, a marriage falling apart, a suicide attempt that didn't take — but the shape is the same. A person tries psilocybin mushrooms, something cracks open, and they describe themselves afterwards as a different human being. If you're reading this, you've probably read a few of those stories. Maybe you're wondering if the same thing could happen to you. I've spent years around plant medicine and psychedelic retreats — sitting in ceremonies, interviewing facilitators, and talking with people six months and six years out from their experiences. So I want to give you an honest answer to the question those testimonies raise. Can mushrooms genuinely change a life? Sometimes, yes. Should you fly to Jamaica or the Netherlands next month? That depends on things worth thinking through carefully. The pattern isn't random. Psilocybin — the active compound in “magic” mushrooms — has been studied for treatment-resistant depression, alcohol use disorder, tobacco addiction, end-of-life anxiety, and OCD, and the results in several trials have been striking. Not miraculous, not universal, but striking enough that Johns Hopkins, NYU, and Imperial College London have built dedicated psychedelic research centers around them. Some participants in these studies describe a single high-dose session as one of the most personally meaningful events of their lives, ranking it alongside the birth of a child. That's an unusual thing for a drug to do. Most substances numb, stimulate, or distract. Psilocybin, at a ceremonial dose in a supportive setting, tends to do something different — it seems to loosen the mental patterns people are stuck in. A drinker who has been telling themselves a story for twenty years about why they need to drink can, in the space of an afternoon, suddenly see that story from the outside. Whether that new perspective sticks is another matter, and that's the part the internet posts usually skip. Forget the giggly college trip. A ceremonial or therapeutic dose of psilocybin — roughly 3 to 5 grams of dried Psilocybe cubensis, or an equivalent tea — is a several-hour immersion in your own psyche. Most well-run experiences involve lying down, eye shades, curated music, and a trained sitter or facilitator in the room. Nobody is trying to entertain you. The intention is to let whatever wants to come up, come up. People often describe a first hour of building intensity — the room breathing, colors sharpening, a sense of some threshold approaching. Then, somewhere in the second hour, the material starts arriving. It might be visual, symbolic, and unfamiliar. It might be a memory you haven't touched since childhood. It might be a wave of grief for a parent, or a startlingly plain recognition of how you've been treating someone you love. The mushrooms don't hand you insights so much as get out of the way of ones you've been avoiding. A few things worth knowing about the experience itself: The strongest evidence right now is for treatment-resistant depression and for alcohol and tobacco addiction. A 2022 JAMA Psychiatry trial found that two psilocybin sessions, paired with therapy, reduced heavy drinking days by about 83% over an eight-month follow-up in participants with alcohol use disorder. A Johns Hopkins pilot in tobacco smokers reported abstinence rates at six months that dwarfed anything standard cessation programs achieve. The depression trials, including the Compass Pathways COMP360 studies, have shown meaningful symptom reduction in a substantial minority of people who had already failed multiple conventional treatments. Important caveats, though. These trials pair psilocybin with structured preparation and integration therapy — usually eight to twelve hours with a trained clinician spread across weeks. The drug alone is not the intervention; the drug inside a therapeutic container is. That distinction matters when you're comparing a clinical trial to a weekend retreat. And even in the best trials, a real percentage of people don't respond, and a smaller percentage feel worse afterwards, at least in the short term. If you're weighing psilocybin as part of an addiction recovery path, understand that no serious researcher describes it as a standalone cure. It appears to give people a window — a few weeks where old patterns feel less inevitable and new choices feel possible. What you do with that window is the actual recovery work. Not everyone is a good candidate. If you or a close family member have a history of psychotic disorders, bipolar I, or schizophrenia, most reputable facilitators will decline your application — and you should take that seriously rather than trying to work around it. Certain medications, particularly SSRIs and lithium, interact with psilocybin in ways that either blunt the experience or, in the case of lithium, may raise the risk of seizure. A responsible retreat will ask about all of this in a screening call. If they don't, that's a red flag. Some other things worth checking before you send a deposit: Cost varies widely — a well-run four to six day mushroom retreat currently runs anywhere from about $1,800 on the modest end to $6,000+ at high-end venues. That's before flights. If a program is priced dramatically below the range, ask what's being cut. Usually it's staff ratio, integration support, or medical screening. The experience is not the healing. The weeks and months afterwards are. People who see lasting change from psilocybin tend to be the ones who do something with what came up — start therapy, change their environment, end a relationship they'd been avoiding ending, get sober, actually call the family member. People who treat the ceremony as the entire event often report a magical few weeks and then a slow slide back to baseline. There's also a risk nobody advertises: opening yourself up in a five-hour session and then flying home to a life that hasn't changed can be destabilizing. Integration — the structured processing of what happened — isn't optional if you want durable results. A good retreat builds that in. If yours doesn't, arrange it independently with a therapist who has psychedelic experience. And one more honest note. The people whose lives genuinely change tend not to be shopping for a peak experience. They tend to be arriving with a specific problem they can no longer solve on their own, a willingness to look at hard things, and a plan for what happens after they land. If that description fits you, a retreat may be worth serious consideration. If you're mostly curious about the visuals, a lower-dose experience with a trusted guide closer to home is probably a better first step. The stories you've been reading are real. Psilocybin has helped people move through things that decades of talk therapy couldn't touch. It has also disappointed people who expected it to do the work for them. Somewhere between those two truths sits the honest answer to whether it's right for you. If, after reading this, you want to look at what's actually available, a range of vetted psilocybin and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision. The mushrooms, and your life, will still be there next month.
OCD, Fear of Death, and Psychedelic Therapy: What Actually Helps
There's a particular kind of fear that doesn't get talked about much in polite company. The 3 a.m. kind. The one that wakes you up convinced you're going to die — not eventually, but soon, and in a way you can't stop. If you live with OCD, especially the flavor that fixates on mortality, you already know this territory. And if you've landed on this page, you're probably wondering whether ayahuasca, psilocybin, or another psychedelic could help quiet the noise. Short answer: maybe. Longer answer: it depends on the person, the substance, the setting, and how honest you're willing to be with a facilitator about what's actually going on in your head. Let's get into it. OCD isn't just liking things tidy. It's a neurological loop — an intrusive thought arrives, the brain tags it as threatening, and a compulsion kicks in to neutralize the anxiety. Rinse, repeat, for hours. When the intrusive theme is mortality — sudden illness, unexplained symptoms, the fear of not existing — the compulsions tend to be mental rather than visible. Constant body-scanning. Googling symptoms at 2 a.m. Silently reassuring yourself, then doubting the reassurance, then reassuring again. The exhausting part is that it feels like thinking. It masquerades as caution, as responsibility, as being on top of things. But it's a rut worn so deep the brain can't climb out on its own. Traditional treatments — SSRIs, exposure and response prevention (ERP) therapy — help a lot of people, and they should always be the starting point. But for a subset of folks, the loop just doesn't quit. That's often where the psychedelic conversation begins. Interest in psychedelics for OCD isn't new. A small but influential study at the University of Arizona back in 2006 gave psilocybin to nine people with treatment-resistant OCD, and every single participant reported reductions in obsessive symptoms during the sessions — some lasting well beyond the acute experience. More recent trials at Yale and elsewhere have been picking up that thread with better methodology. The working theory is that classic psychedelics — psilocybin, LSD, ayahuasca's DMT — temporarily loosen the brain's default mode network, which is the same circuitry hyperactive in rumination and obsessive thinking. When that network goes quiet, the mental grooves that OCD carves become, for a few hours, negotiable. People describe stepping outside the loop and looking at it from the outside for the first time in years. Ayahuasca specifically has a growing anecdotal track record with existential fear. The brew tends to hand people direct experiences of ego-dissolution — often mistaken for or overlapping with the fear of death itself. Which sounds terrifying, and sometimes is. But many people come out the other side with the fear noticeably softened, because they've already been to the edge of it and returned. Here's what a lot of retreat marketing skips: psychedelics can also make OCD worse, at least temporarily, and in some cases longer. A high-dose experience can hand someone with death-anxiety exactly the raw material their disorder feeds on. The ego-dissolution that helps one person can trigger months of derealization in another. This isn't a rare edge case — it happens often enough that any serious facilitator should be asking about your mental health history in detail before accepting you. Some specific risks worth naming: None of this is a reason to rule out plant medicine. It's a reason to plan carefully. The bar for choosing well is higher when your nervous system is already primed for spirals. A few things I'd look for, and questions I'd ask before wiring any deposit: Ibogaine and 5-MeO-DMT deserve a special note here: both are extraordinarily powerful and, in my view, not first-choice medicines for someone whose primary struggle is death-anxiety-based OCD. The intensity can be destabilizing rather than clarifying. Psilocybin or ayahuasca in a well-supported setting tend to be gentler entry points, if entry is warranted at all. The people who report the best outcomes almost always did substantial work before they showed up. That means: One thing I'd add from experience: tell your facilitator about the OCD before the first ceremony, not after something scary happens. The urge to hide it — to seem "ready," to not be the difficult participant — is strong. Resist it. A good facilitator will adjust dose, ceremony structure, and post-session support based on what they know. For people who do get relief, it rarely arrives as a dramatic before-and-after. More often it's a gradual softening. The intrusive thought still shows up, but it doesn't grip as hard. You notice it and the noticing itself creates a little space. The 3 a.m. panic happens less often. When it does, you can breathe through it instead of spending the next four hours in a symptom search. Some people describe the fear of death getting reframed rather than eliminated — moving from something that stalks them to something that feels, oddly, like a companion. Not welcome, exactly, but no longer catastrophic. That's not everyone's experience, and it's not a promise. But it's a real pattern that shows up often enough in the reports to be worth naming. Psychedelic therapy for OCD isn't a shortcut around the work. It's a possible amplifier for work you're already doing. If your ERP therapist has never heard of psilocybin, that's a sign to add support, not swap therapies. If your only exposure to plant medicine has been Instagram testimonials, slow down and read the actual research. And when you're ready to look at what's actually available, a range of screened ayahuasca and psilocybin retreats with proper integration support can be browsed on our marketplace here. Take your time with the decision — the retreat that's right for someone with OCD isn't always the one with the prettiest website.
Gratitude Meditation: A Simple Practice That Actually Changes How You Feel
Somewhere between the third notification and the second cup of coffee, most of us have forgotten to notice anything at all. Gratitude meditation is the small, unfashionable practice of stopping — briefly, deliberately — and letting appreciation surface on purpose. It sounds almost too simple to matter. The research suggests it matters quite a lot. I've spent years around people preparing for and returning from plant-medicine ceremonies — ayahuasca, psilocybin, San Pedro — and one pattern shows up again and again. The participants who integrate their experiences most gracefully tend to already have some kind of daily contemplative practice. Gratitude meditation is one of the easiest on-ramps I know of. No cushion required, no incense, no lineage. Just a few minutes and a willingness to pay attention to what's actually good. At its core, meditation is the practice of pointing your attention somewhere on purpose and gently returning it there when it drifts. That's it. The object can be your breath, a candle flame, a mantra, a body sensation, or — in this case — the specific texture of feeling grateful for something or someone. Researchers describe gratitude meditation as a form of mindfulness practice that focuses awareness, with warmth and care, on the things and people you appreciate. It isn't affirmation. You're not repeating “I am grateful, I am grateful” in your head like a mantra you don't quite believe. You're sitting with the actual felt sense of appreciation and letting it grow. The roots run deep. Buddhist monastics open their day with gratitude chants. Indigenous elders across the Americas begin ceremony by thanking the earth, the sky, the four directions, the plant and animal kin. In Tibetan traditions, practitioners even offer thanks for their suffering — for the way it cracks them open. Long before the word “mindfulness” started appearing on wellness podcasts, humans across cultures were already doing this. Here's the honest answer: gratitude meditation reliably makes you feel more grateful in daily life. That sounds circular until you consider what feeling grateful actually does to a person. People who cultivate gratitude tend to cope better with stress, hold healthier relationships, orient toward meaning rather than material accumulation, and report higher self-esteem. Studies on gratitude-focused meditation specifically have linked it to reductions in anxiety and depressive symptoms — reductions that go beyond what non-gratitude mindfulness practices produce on their own. There's also evidence of better emotional regulation, greater life satisfaction, improved body image, and lower stress markers. None of this is magic. It's the compounding effect of noticing what's already good, over and over, until noticing becomes the default. The brain gets very good at whatever you rehearse. Most of us have been rehearsing complaint for years without meaning to. This is the part that gets less airtime, and it's the part I care about most. Ayahuasca, psilocybin, ibogaine, and other master plants tend to produce experiences of profound thankfulness — a kind of raw, uncomplicated appreciation for being alive, for the people who've loved you, for the mystery of the whole thing. Ceremony participants often describe weeping with gratitude at three in the morning for reasons they can't articulate the next day. The problem is that these openings fade. Two weeks after a retreat, the ordinary noise of life reasserts itself. This is where integration lives or dies. A gratitude meditation practice — even a short one — is one of the most effective ways I've seen people extend and stabilize what the medicine showed them. It's a bridge between the ceremony room and Tuesday morning. For anyone working through addiction recovery, this matters double. Addiction is, among other things, a disorder of what the mind attends to. Craving hijacks attention. Gratitude practice is a slow, quiet rewiring of where the mind rests when it's not being pulled. Combined with psychedelic-assisted work — whether that's ibogaine for opioid dependence, psilocybin for alcohol use, or ayahuasca for the deeper trauma often underneath — a daily gratitude sit becomes something like scaffolding. The medicine opens the door. The practice keeps you walking through it. You don't need an app, a teacher, or a special posture. Here's a version that works. It takes about ten minutes, though five is plenty on a busy day. That's the whole thing. Do it once and it's a nice moment. Do it daily for a month and something shifts. A few things nobody mentions. First, don't force gratitude that isn't there. Manufactured thankfulness is worse than none — it teaches you to lie to yourself, which is the opposite of what any real contemplative practice is for. If you sit down and feel numb, sit with the numbness. If you feel grief, sit with the grief. The gratitude will come back on its own timeline. Second, gratitude practice is not a bypass. It doesn't excuse bad situations, abusive relationships, or the very real pain of unresolved trauma. Some people — especially those with heavy trauma histories — find that trying to force positive states creates more internal conflict. If that's you, work with a therapist or an experienced integration coach, particularly if you're combining this with plant medicine. Third, gratitude for suffering is an advanced move. Tibetan monks can pray thanks for their difficulties because they've been at this for decades. If you're three weeks out from a hard ceremony and someone tells you to be grateful for your trauma, feel free to ignore them. That kind of orientation, if it comes, arrives on its own. What I've come to believe, after enough ceremonies and enough conversations with people rebuilding their lives after them, is that the big experiences aren't what change us. The small daily returns are. A ten-minute sit doesn't sound like much next to a night in the maloca. But the sit is what makes the night stick. Whether you're preparing for your first ayahuasca retreat, integrating a psilocybin experience, working through addiction recovery, or just tired of feeling ambient dread every time you check your phone — this practice costs nothing and asks almost nothing. Try it for a week. See what happens. And if this article has you thinking about how gratitude practice might fit into a fuller plant-medicine journey, a curated selection of ayahuasca and psychedelic retreats — many with strong integration and contemplative components — can be browsed on our marketplace here.
OCD and the Inner Voice: Can Plant Medicine Quiet the Noise?
Anyone who's lived with OCD knows the inner voice isn't really a voice. It's a loop. A relentless, high-pitched negotiation with yourself about things nobody else would spend two seconds on. Did I lock the door. Am I a bad person. What if that thought means something. What if it means nothing and that's worse. Lately I've been getting more questions from readers with OCD, intrusive thoughts, and treatment-resistant anxiety who are wondering whether ayahuasca, psilocybin, or another plant medicine might help them turn the volume down. It's a fair question, and the honest answer is complicated. Psychedelics aren't a shortcut around OCD, but there's a growing conversation — and some real research — about what plant medicine can and can't do for people wired this way. OCD isn't just anxiety with extra steps. It's a specific pattern: intrusive thoughts arrive uninvited, the brain reads them as threats, and compulsive behaviors show up to neutralize the discomfort. The relief lasts about ninety seconds. Then the loop restarts. If you've been in it since childhood, as many readers have, the loop feels less like a symptom and more like the shape of your mind. Here's where things get interesting. Psychedelics — ayahuasca especially, but also psilocybin — tend to loosen the grip of rigid mental patterns. Neuroimaging studies going back over a decade suggest these substances quiet the default mode network, the part of the brain that runs the endless self-referential commentary most of us call thinking. For someone with OCD, that commentary is turned up to eleven. The theory, at least, is that plant medicine can crack the loop open long enough for the person to see it from outside. The theory is compelling. The practice is messier. A ceremony can just as easily amplify obsessive content as dissolve it. If your intrusive thoughts are about contamination, or harm, or losing control — congratulations, ayahuasca is going to hand you five hours of exactly that material and ask what you want to do with it. The clinical picture is small but real. A pilot study at the University of Arizona back in 2006 gave psilocybin to nine adults with OCD and reported significant reductions in symptom scores across all participants, sometimes lasting well beyond the session. Since then, larger trials have been slow to arrive, but a handful of ongoing studies at Yale and elsewhere are looking specifically at psilocybin for treatment-resistant OCD. Early signals are cautiously positive. Ayahuasca research is thinner and mostly focused on depression, addiction, and PTSD rather than OCD specifically. But the anecdotal reports from long-term retreat facilitators are consistent: people with obsessive patterns can experience meaningful shifts, particularly when the medicine surfaces the emotional root underneath the compulsions rather than the compulsions themselves. The vine, as Amazonian curanderos will tell you, tends to show you what you've been avoiding. For people with OCD, what's being avoided is usually not the intrusive thought itself — it's the feeling the thought is protecting them from. None of this qualifies as a treatment recommendation. It's a live area of study, and if you're on SSRIs (which many OCD patients are), the interaction risks with ayahuasca specifically are serious. More on that in a moment. In the Amazonian tradition, ayahuasca is one of many plants considered maestros — teachers. San Pedro, tobacco (used ceremonially, not smoked recreationally), bobinsana, chiric sanango, and others each have their own reputation for what they teach. Facilitators who work with people carrying anxiety and obsessive patterns often lean toward the more heart-opening, grounding plants rather than jumping straight into ayahuasca. What tends to shift after a good ceremony, based on what participants describe: What doesn't tend to shift, at least not from a single retreat: If you're taking an SSRI for OCD — sertraline, fluoxetine, escitalopram, and their cousins — ayahuasca is a hard no without a careful, medically supervised taper. The MAOI component in ayahuasca (that's what makes the DMT orally active) combined with SSRIs can trigger serotonin syndrome, which ranges from unpleasant to life-threatening. Reputable retreats will screen for this. Sketchy ones won't. That's your first filter when evaluating any center. Psilocybin has a lower interaction profile with SSRIs but the antidepressants tend to blunt the psilocybin experience, sometimes to the point of the session doing very little. Some clinicians will support a taper under supervision; others won't. There's no clean rule here, and anyone who tells you there is should not be your guide. Beyond medication, there's the deeper question of whether an intense psychedelic experience is even the right move when your baseline mental state is already characterized by hypervigilance and fear of losing control. For some people with OCD it's the exact medicine they needed. For others it's five hours of a bad time that reinforces the very patterns they came to break. The people who tend to do well have usually done substantial therapy first, have a stable life circumstance, and approach the ceremony without white-knuckling for a specific outcome. If, after all the caveats, you still feel drawn to explore plant medicine for your OCD or the addiction patterns that so often ride alongside it, the retreat you choose matters more than almost anything else. A few things worth weighing: Cost varies wildly — anywhere from around $1,500 for a modest week in Peru to $8,000 or more for boutique centers in Costa Rica or the Netherlands. Price doesn't equal quality, but suspiciously cheap is its own red flag. Plant medicine can help. It can also do nothing. It can also make things temporarily worse before it makes them better, and “better” for someone with lifelong OCD usually means a manageable relationship with the loop rather than the disappearance of it. Anyone promising more than that is selling something. The people I've watched get the most out of ayahuasca or psilocybin for obsessive thinking are the ones who treated the ceremony as one intervention among several — alongside good therapy (ERP is the gold standard for OCD), medication when needed, sleep, movement, and the boring daily work of learning to sit with discomfort instead of solving it. The medicine opens a door. Walking through it is still your job. If you've been circling this decision for a while, that's probably a good sign — OCD makes everything take longer, and taking your time here is warranted. For readers who want to keep exploring, a range of vetted ayahuasca and psilocybin retreats that screen carefully and offer integration support can be browsed on our marketplace here. Whatever you decide, decide it slowly, with people who know your history, and with your eyes open to what plant medicine actually is — a powerful tool, not a rescue.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
